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Abstract
Approximately 80% of patients who are successfully resuscitated from cardiac arrest do not regain
consciousness immediately after return of spontaneous circulation, and may remain in a coma for
hours or weeks, or even be in a persistent vegetative state. Recent investigations have focused on the
identification of early clinical characteristics and biomarkers that can reliably predict emergence from
coma in those who survive, and on therapies that might improve neurologic outcome from the
ischemic brain injury that can be caused by cardiac arrest.
Introduction and context
Cardiac arrest results in the cessation of spontaneous
circulation, which causes hypoxic-ischemic encephalo-
pathy, the severity of which is primarily related to the
time from arrest to restoration of spontaneous circula-
tion. Prolonged intervals without spontaneous circula-
tion result in death, long-term or permanent coma,
persistent vegetative state, seizures, and myoclonus [1].
Predicting the outcome following cardiac arrest for
survivors who are comatose following resuscitation is
the source of much consternation among emergency
room and intensive care unit (ICU) physicians, as well as
family members. As acute care resources have become
increasingly scarce and costly, there has been increasing
emphasis on identifying clinical, imaging, or molecular
biomarkers that can reliably predict long-term outcome.
The Quality Standards Subcommittee of the American
Academy of Neurology has published a ‘Practice Para-
meter’ regarding prediction of outcome in comatose
survivors of cardiac arrest [2]. That evidence-based review
found that pupillary light response, corneal reflexes,
motor responses to pain, myoclonic status epilepticus,
serum neuron-specific enolase (NSE), and somatosen-
sory evoked potential (SSEP) studies can reliably assist in
accurately predicting poor outcomes in comatose
patients. NSE is an enzyme active in the glycolytic
pathway and is released from peripheral and central
neurons when they are damaged. The strongest pre-
dictors of outcome are the absence of the pupillary light
response, absence of corneal reflexes, and extensor or no
motor response to pain for at least 3 days after the arrest.
Questions remain, however, about the sensitivity and
specificity of serum biomarkers, as well as the role of
imaging and electrophysiologic biomarkers.
There also has been intense interest in identifying
therapies that may limit secondary brain injury after
cardiac arrest. During the 1990s several pre-clinical
studies found that therapeutic resuscitative hypothermia
was very effective in improving neurologic recovery after
arrest for various lengths of time. In 2002 the results of
two large multicenter clinical trials were reported and
they showed that patients with out-of-hospital cardiac
arrest (OHCA) and an initial rhythm of ventricular
fibrillation had a significantly better neurologic outcome
if they were cooled to 32-34°C for 12-24 hours after the
arrest [3,4]. Based on the positive results of those trials,
the advanced life support task force of the International
Liaison Committee on Resuscitation recommended
therapeutic moderate hypothermia for patients with
OHCA and ventricular fibrillation as the initial rhythm
[5]. Subsequent clinical studies have documented as
much as a twofold increase in the rate of good outcomes
for this subgroup of OHCA patients treated with
therapeutic hypothermia [6]. Several questions remain,
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and its benefit for other subgroups of patients with
cardiac arrest, such as those with post-arrest rhythms of
asystole or electro-mechanical dissociation.
Recent advances
Prognosis
Clinical risk factors associated with poor outcome after
cardiac arrest continue to be extensively studied in the
search for one or a combination of features with high
enough specificity and sensitivity to be clinically reliable.
In one cohort of 149 patients with OHCA who had
initiation of professional cardiopulmonary resuscitation
and who survived long enough to be hospitalized, 25.5%
survived for at least 3 years [7]. The strongest predictors
for long-term survival were age under 70 years, ventri-
cular fibrillation as the initial rhythm, cardiopulmonary
resuscitation without atropine, and ST-segment elevation
myocardial infarction. In fact, the subgroup with ST-
segment elevation myocardial infarction had a 1-year
survival of 57.7%. Other recent studies also show that
clinical findings independently associated with death or
severe disability are older age, the presence of chronic
obstructive pulmonary disease, the absence of corneal
and pupillary reflexes, myoclonus, and, to a lesser extent,
extensor or absent motor responses to painful stimuli
[8-10]. In addition, duration of cardiac arrest greater than
25 minutes, defined as time from collapse to return of
spontaneous circulation, is strongly associated with such
poor outcomes [11,12] (Table 1).
The early onset of generalized myoclonic status is an
ominous sign, although there is at least one case report of
a patient who regained consciousness after successful
treatment of the status [13]. Seizures may contribute to
mortality, morbidity, and to increased ICU length of
stay. In addition, most agree that a neurologic assess-
ment-based prognosis of patients should be considered
unreliable for at least the first 72 hours after the arrest,
and particularly for those patients receiving therapeutic
hypothermia [14].
Some have also raised concerns that subclinical or
nonconvulsive status epilepticus may be an important
cause of prolonged coma after cardiac arrest. But
electroencephalograms (EEGs) obtained from 169
patients admitted alive but comatose after OHCA found
only two patients with EEG evidence of generalized
myoclonic status without clinical manifestations [15].
Molecular biomarkers
Cardiac arrest and loss of spontaneous circulation causes
global cerebral ischemia. Molecular markers of neuronal
distress might be expected to be elevated in proportion
to the severity of ischemia, and thereby reflect the
likelihood of prolonged coma. NSE levels of 80 ng/ml or
higher have been found to predict persistent coma after
OHCA with a sensitivity of 63%, specificity of 100%,
positive predictive value of 100%, and a negative
predictive value of 84% [16,17]. Thus, a serum NSE
concentration exceeding 80 ng/ml is a highly specific but
only moderately sensitive marker for death or severe
neurological disability after resuscitation. Amaraz et al.
[16] did conclude that the specificity of serum NSE levels
>80 ng/ml is sufficiently high that, when used with other
clinical and electrophysiological data, it could be useful
as a prognostic indicator of neurologic outcome after
cardiac arrest [16]. And in a prospective study of 80
patients successfully resuscitated after cardiac arrest,
Prohl and colleagues [18] used multivariate logistic-
regression analysis to show that 85% of the variance in
the dichotomized Cerebral Performance Category (CPC)
scores at 1 and 6 months after arrest could be explained
by NSE levels at day 4, clinical examination score at day
4, and age, with a sensitivity of 92% and a specificity of
93%. There is some preliminary evidence that NSE may
be unreliable as a predictor of poor outcome when
patients have been treated with hypothermia, however.
NSE serum levels obtained from 12 to 36 hours after the
arrest also have been found to be predictive of 6-month
outcomes for patients with in-hospital cardiac arrest
[19]. Those who achieved a favorable outcome, defined
as mild, moderate, or no disability, had a median NSE
level of 25 ng/ml, while those with a GOS (Glasgow
Outcome Scale) score of 1-3 (dead, vegetative, or severely
disabled) had a median serum NSE level of 44 ng/ml.
S-100B is a relatively non-specific biomarker of neuronal
distress, and serum levels are elevated in a variety of
stress related conditions. In one study of the ability of
S-100B to predict outcomes for comatose OHCA patients
at hospital discharge, S-100B was found to have a
sensitivity of 100%, but a specificity of only 38% [20].
Threshold levels of serum S-100B at 24-48 hours after
OHCA have been identified that predict moderate to
Table 1. Clinical characteristics of poor outcomes for patients
who remain comatose after cardiac arrest
*
Absent papillary light reflexes
Absent corneal reflexes
Extensor or no motor response to pain
Age greater than 70 years
Non-ventricular fibrillation as initial post-arrest rhythm
Duration of arrest greater than 25 minutes
Presence of chronic obstructive pulmonary disease
Myoclonic status
Serum neuron specific enolase levels >80 ng/ml
N-20 waves of somatosensory evoked potentials absent bilaterally
* Most reliable when assessed 72 hours or more after the arrest.
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that predict in-hospital death with absolute specificity
also have been defined, but sensitivity is less than 50%,
so at present most conclude that serum S-100B is not a
clinically useful biomarker for outcome prediction [21].
Others have focused on serum levels of the cardiac
neurohormone B-type natriuretic peptide, and found
that, in 109 patients with OHCA who survived to be
evaluated in the emergency room, a level of 80 pg/ml or
less was an independent predictor of favorable neurolo-
gical outcome [22].
Imaging biomarkers
The relationship between the clinical manifestations of
hypoxic-ischemic encephalopathy following cardiac
arrest, and anatomic brain injury, is not entirely clear.
In some cases at least, prolonged coma or vegetative state
may be more due to a disruption of cerebral physiology
than to anatomic injury. In one post-mortem study of 41
patients who fulfilled standard clinical criteria for brain
death prior to discontinuation of life-support measures,
only mild histologic change was present in one-third of
the patients, though it should be noted that only two of
these patients had cardiac arrest as their primary
diagnosis – the rest were traumatic brain injury [23].
No distinctive neuropathologic features of brain death
could be identified. However, there also is evidence for
pathognomonic ischemic histopathology. For example,
diffuse axonal injury is more common after traumatic
brain injury; cytotoxic edema is most common after
ischemic stroke; and cortical laminar necrosis is most
common after cardiac arrest. As a result, there is some
rationale for using magnetic resonance imaging (MRI)
to identify early ischemic injury and distinguish the
cause [24].
In a study of 80 comatose patients with cardiac arrest
who underwent diffusion-weighted MRI, a reduction of
the whole-brain apparent diffusion coefficient (ADC)
was a significant predictor of death or severe disability
[25]. The differences in ADC between those with a good
versus those with a poor outcome were most prominent
in the occipital and parietal lobes. Others also have
found that the largest number of diffusion changes
indicative of acute ischemia are seen in patients who die,
and such changes are most common in the parietal lobes
[26]. Diffusion-weighted MRI-based ADC thresholds for
recovery of function and survival were defined in a very
recent paper by Christine et al. [27]. Timing of the MRI
relative to seizures is very important because seizures can
cause reversible changes in the ADC map that are not
related to prognosis.
A recent study of functional MRI also found a correlation
between the level of BOLD (blood oxygenation-level
dependent) activation of the primary sensory cortex
following stimulation of the palm of the hand, and
survival at 3 months [28].
Electrophysiologic biomarkers
SSEPs are most helpful for predicting which patients will
die or remain in a persistent coma following OHCA. In
particular, the bilateral absence of the N20 potential is a
very good predictor of death or persistent vegetative
state. The PROPAC study of 407 patients from the
Netherlands found that bilaterally absent early cortical
responses (N20) following stimulation of the median
nerve is the most reliable predictor of poor outcome, and
especially the likelihood that the patient will not regain
consciousness [10].
However, SSEPs are not very useful for predicting good
outcomes, such as who will regain normal or near
normal neurologic and cognitive functioning. While
some have found a weak correlation between retention
of the N20 waveform and such good outcomes [28], a
study of 319 patients with coma following cardiac arrest
found that only 28% of those with normal N20 and N70
potentials had a good outcome [29].
The continuous analyses of the EEG with the bispectral
index (BIS) monitor also has been used to predict
outcomes. In one study of 14 patients with coma after
cardiac arrest, all 11 patients who had BIS values of zero
either died or had severe neurologic deficits at 6 months
after the arrest [30]. Again, however, BIS monitoring was
not useful for predicting who would have complete
neurologic and functional recovery, and 11 out of 31
patients with BIS values higher than zero died, while 17
had no or minor neurologic deficits 6 months after
cardiac arrest.
It is very important to remember that EEG is suppressed
by anesthetic agents and by hypothermia, both of which
may produce electro-cerebral silence and burst suppres-
sion [31]. SSEP is less susceptible to sedative and
anesthetic agents, but hypothermia has been shown to
prolong evoked potential latencies.
Treatment of comatose cardiac arrest patients
Therapeutic hypothermia is now considered standard of
care for patients with OHCA and ventricular fibrillation
as the initial rhythm, though clinical trials continue to be
conducted to better define the benefits of the therapy,
treatment parameters, and duration of effect. However,
contemporary clinical trials no longer randomize
patients to a normothermia arm. One study of 52
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33% shorter length of ICU stay compared to historical
normothermic controls [32]. In another study of OHCA,
79 patients who received hypothermia and were alive at
hospital discharge had significantly better CPC scores
compared with 77 patients who did not receive
hypothermia and were admitted to the same hospital
during the 2 years prior to the hypothermia treated group
[33]. However, at 6 months after the arrest there was no
difference in the Mini Mental Status Examination or the
SF-36, a self-rated quality of life assessment, between the
hypothermia and normothermia groups.
The impact of the rate of cooling on outcome is
controversial. A review of the Swedish Hypothermia
Registry of 975 patients with OHCA revealed that half of
the patients who survived had minimal or no neurolo-
gical deficits at long-term follow-up, but neither the time
to initiation of therapeutic hypothermia nor time to
reach target temperature had any effect on outcomes
[34]. A separate study of 22 patients treated with
hypothermia in the pre-hospital setting by infusion
with large volumes of cold intravenous saline also found
that, compared with 77 consecutive patients treated with
standard prehospital resuscitation, there was no differ-
ence in the rate of good outcome at 1 year after the arrest
[35]. However, a study of the use of endovascular cooling
technology in 49 consecutive patients resuscitated from
cardiac arrest found that the time to reach 33°C was an
independent predictor of recovery of normal neurologic
ability, and that those patients who reached target
temperature the soonest also had the lowest serum
levels of NSE [36].
For comatose patients with ST-segment elevation asso-
ciated with acute myocardial infarction, there also is
evidence that primary percutaneous coronary interven-
tion to restore coronary perfusion, and therapeutic
hypothermia, can safely be combined to improve
outcomes in this subgroup of OHCA patients [37,38].
Hypothermia still has not been found to improve
outcomes for those with nonventricular fibrillation
rhythms, such as asystole or pulseless electrical activity,
when cardiopulmonary resuscitation is begun [6].
Implications for clinical practice
During the past 2-3 years several studies have better
defined the clinical characteristics, and molecular and
electrophysiologic biomarkers that can be reliably used
to predict poor long-term outcomes for those who
survive OHCA. Thus, patients who are comatose and
have absent pupillary and corneal reflexes, no sponta-
neous circulation after arrest for more than 25 minutes,
are older than age 70, and have serum NSE levels greater
than 80 ng/ml and bilaterally absent N20 waves on
SSEPs 3 or more days after the arrest will have a poor
long-term outcome. Unfortunately, however, there still
has been little progress toward defining clinical or
laboratory characteristics that will reliably predict good
outcomes. No new therapies for OHCA have been
identified, but recent trials have better defined the
short- and long-term effects of therapeutic hypothermia.
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